Navigating 4 Analyst Ratings For LeMaitre Vascular
Portfolio Pulse from Benzinga Insights
LeMaitre Vascular (NASDAQ:LMAT) has received diverse analyst ratings over the past three months, with a mix of bullish and somewhat bullish sentiments. Analysts have set a 12-month average price target of $82.75, reflecting a 24.12% increase from the previous target. Key analysts have raised their price targets, indicating positive expectations for the company's performance.
May 31, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LeMaitre Vascular has received a mix of bullish and somewhat bullish ratings from analysts over the past three months. The average 12-month price target has increased to $82.75, a 24.12% rise from the previous target. Key analysts have raised their price targets, indicating a positive outlook for the company's performance.
The increase in the average price target and the positive ratings from key analysts suggest a favorable short-term outlook for LeMaitre Vascular. The raised price targets indicate confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100